CLSD: Clearside Biomedical, Inc. Stock

by  •  • Comments Off on CLSD: Clearside Biomedical, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 71.74
Enterprise Value ($M) 103.49
Book Value ($M) -38.85
Book Value / Share -0.50
Price / Book -1.85
NCAV ($M) -43.96
NCAV / Share -0.57
Price / NCAV -1.63

Profitability (mra)
Return on Invested Capital (ROIC) -2.52
Return on Assets (ROA) -0.86
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 4.18
Current Ratio 4.18

Balance Sheet (mrq) ($M)
Current Assets 20.02
Assets 25.13
Liabilities 63.98
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 1.66
Operating Income -28.88
Net Income -34.35
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -24.70
Cash from Investing -0.64
Cash from Financing 16.44

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
3 days ago 13G Wiles Stephen Boyd 5.20
03-04 13G/A Whitmore Bradford T 8.60 4.13
02-21 13D/A Hatteras Venture Advisors IV SBIC, LLC 0.40

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-03-27 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K
2024-11-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-08-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-05-10 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-03 29,401 115,255 25.51
2025-04-02 11,555 54,869 21.06
2025-04-01 39,257 109,991 35.69
2025-03-31 18,331 84,683 21.65

(click for more detail)

Similar Companies
CADL – Candel Therapeutics, Inc. CARM – Carisma Therapeutics, Inc.
CHRS – Coherus BioSciences, Inc. CLYM – Climb Bio, Inc.
CMRX – Chimerix, Inc.


Financial data and stock pages provided by
Fintel.io